Home » Topics » Regulatory

Regulatory
RSS

BMS seeks approval in U.S. for Glucophage XR tablets

Nov. 22, 1999

Small patient study indicates potential new indication for leflunomide

Nov. 17, 1999

FDA accepts NDA for tacrolimus ointment

Nov. 16, 1999

Ciba Vision introduces ocular formulation of lomefloxacin in U.K.

Nov. 15, 1999

Synvisc under study for osteoarthritis of the hip

Nov. 11, 1999

Important new indication for Remicade approved by FDA

Nov. 11, 1999

Amgen's epoetin alfa approved in children with chronic renal failure

Nov. 8, 1999

Glaxo Wellcome files for approval of new Relenza indications: influenza prophylaxis, pediatric use

Nov. 8, 1999

Nasonex Nasal Spray approved in E.U. for use in young children

Nov. 8, 1999

First approval granted for Melacine melanoma therapeutic vaccine

Nov. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...